NCT06243978 Effectiveness of a Digital Health Application for Primary Hypertension (Liebria)
| NCT ID | NCT06243978 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gaia AG |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 328 participants |
| Start Date | 2024-04-02 |
| Primary Completion | 2025-04-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 328 participants in total. It began in 2024-04-02 with a primary completion date of 2025-04-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial with 328 patients with primary hypertension aims to investigate the effectiveness of the self-guided digital application liebria for patients with primary hypertension.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 * Presence of primary hypertension, confirmed by submission of a medical certificate or equivalent (e.g., informal letter signed by primary care physician); relevant ICD-10-GM diagnoses: * I10.00 (Benign essential hypertension: Without indication of hypertensive crisis) * I10.90 (Essential hypertension, unspecified: Without indication of hypertensive crisis) * Unmedicated or with existing antihypertensive drug therapy (with stable dose in the past 6 weeks prior to study enrolment) * Last reported office-based systolic blood pressure (SBP) ≥ 140 mmHg followed by home-based SBP ≥ 135 mmHg * Consent to participate Exclusion Criteria: * Home-based SBP \> 180 mmHg * \> Triple combination of antihypertensive medication * History of secondary hypertension (e.g., thyroid disease, kidney disease) * Pregnancy
Contact & Investigator
Kamila Jauch-Chara, MD
PRINCIPAL INVESTIGATOR
University Hospital Schleswig-Holstein
Frequently Asked Questions
Who can join the NCT06243978 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06243978 currently recruiting?
Yes, NCT06243978 is actively recruiting participants. Contact the research team at gitta.jacob@gaia-group.com for enrollment information.
Where is the NCT06243978 trial being conducted?
This trial is being conducted at Hamburg, Germany.
Who is sponsoring the NCT06243978 clinical trial?
NCT06243978 is sponsored by Gaia AG. The principal investigator is Kamila Jauch-Chara, MD at University Hospital Schleswig-Holstein. The trial plans to enroll 328 participants.